Who Buys Gentamicin from India — 1180 Importers Behind a $51.0M Market

The 1,180 buyers of Gentamicin from India can be categorized into several segments:

1. Distributors: Entities that purchase Gentamicin in bulk to supply to various healthcare providers. For instance, HEKO PHARMACY LTD in Tanzania, the top buyer with imports totaling $5.93 million, likely operates as a distributor, given the substantial volume of their purchases.

2. Hospital Groups: Large healthcare institutions or networks that procure Gentamicin directly for patient care. While specific hospital groups are not identified among the top buyers, it's common for such entities to engage in direct procurement to ensure a steady supply for their facilities.

3. Retail Chains: Pharmacy chains that stock Gentamicin for over-the-counter sales or prescription fulfillment. AYUL INTERNATIONAL TRADING LLC in Côte d'Ivoire, with imports amounting to $3.29 million, may represent this segment, supplying Gentamicin to various retail outlets.

4. Government Procurement: National health agencies or international organizations like UNICEF and the Global Fund that acquire Gentamicin for public health initiatives. While not explicitly listed among the top buyers, such entities often engage in large-scale procurement through tenders to support national healthcare programs.

5. Re-exporters: Companies that import Gentamicin with the intent to export it to other markets. EUGIA US LLC in the United States, importing $0.60 million worth of Gentamicin, might function as a re-exporter, distributing the product to other regions.

6. Contract Manufacturers: Firms that import Gentamicin as an active pharmaceutical ingredient (API) for the production of finished dosage forms. While specific contract manufacturers are not highlighted among the top buyers, this segment plays a crucial role in the pharmaceutical supply chain.

For the top five importing countries, the import regulations for Gentamicin are as follows:

The demand for Gentamicin in importing countries is driven by several factors:

1. Disease Prevalence: Gentamicin is a broad-spectrum antibiotic effective against various bacterial infections, including severe infections like sepsis and certain types of pneumonia. High prevalence of such infections in regions like sub-Saharan Africa and parts of Asia increases the demand for Gentamicin.

2. Government Healthcare Programs: Many countries have national health programs that prioritize the treatment of infectious diseases. For example, Tanzania's National Health Policy emphasizes the control of communicable diseases, leading to substantial procurement of antibiotics like Gentamicin.

3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage (UHC) have led countries to ensure the availability of essential medicines. The inclusion of Gentamicin in national formularies supports its widespread use in public health facilities.

4. WHO Essential Medicines List Procurement: Gentamicin is listed on the WHO Model List of Essential Medicines, indicating its critical role in basic healthcare. This listing encourages countries to procure and stock Gentamicin to meet essential healthcare needs.

5. Tender-Based Purchasing: Many governments and international organizations procure medicines through competitive tender processes to ensure cost-effectiveness and supply security. This approach often results in bulk purchasing of Gentamicin, contributing to its significant import volumes.

With 1,180 buyers across 143 countries, the global market for Gentamicin remains robust, reflecting its essential role in treating bacterial infections worldwide.

The 1,180 buyers of Gentamicin from India can be categorized into several segments:

1. Distributors: Entities that purchase Gentamicin in bulk to supply to various healthcare providers. For instance, HEKO PHARMACY LTD in Tanzania, the top buyer with imports totaling $5.93 million, likely operates as a distributor, given the substantial volume of their purchases.

2. Hospital Groups: Large healthcare institutions or networks that procure Gentamicin directly for patient care. While specific hospital groups are not identified among the top buyers, it's common for such entities to engage in direct procurement to ensure a steady supply for their facilities.

3. Retail Chains: Pharmacy chains that stock Gentamicin for over-the-counter sales or prescription fulfillment. AYUL INTERNATIONAL TRADING LLC in Côte d'Ivoire, with imports amounting to $3.29 million, may represent this segment, supplying Gentamicin to various retail outlets.

4. Government Procurement: National health agencies or international organizations like UNICEF and the Global Fund that acquire Gentamicin for public health initiatives. While not explicitly listed among the top buyers, such entities often engage in large-scale procurement through tenders to support national healthcare programs.

5. Re-exporters: Companies that import Gentamicin with the intent to export it to other markets. EUGIA US LLC in the United States, importing $0.60 million worth of Gentamicin, might function as a re-exporter, distributing the product to other regions.

6. Contract Manufacturers: Firms that import Gentamicin as an active pharmaceutical ingredient (API) for the production of finished dosage forms. While specific contract manufacturers are not highlighted among the top buyers, this segment plays a crucial role in the pharmaceutical supply chain.

For the top five importing countries, the import regulations for Gentamicin are as follows:

The demand for Gentamicin in importing countries is driven by several factors:

1. Disease Prevalence: Gentamicin is a broad-spectrum antibiotic effective against various bacterial infections, including severe infections like sepsis and certain types of pneumonia. High prevalence of such infections in regions like sub-Saharan Africa and parts of Asia increases the demand for Gentamicin.

2. Government Healthcare Programs: Many countries have national health programs that prioritize the treatment of infectious diseases. For example, Tanzania's National Health Policy emphasizes the control of communicable diseases, leading to substantial procurement of antibiotics like Gentamicin.

3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage (UHC) have led countries to ensure the availability of essential medicines. The inclusion of Gentamicin in national formularies supports its widespread use in public health facilities.

4. WHO Essential Medicines List Procurement: Gentamicin is listed on the WHO Model List of Essential Medicines, indicating its critical role in basic healthcare. This listing encourages countries to procure and stock Gentamicin to meet essential healthcare needs.

5. Tender-Based Purchasing: Many governments and international organizations procure medicines through competitive tender processes to ensure cost-effectiveness and supply security. This approach often results in bulk purchasing of Gentamicin, contributing to its significant import volumes.

With 1,180 buyers across 143 countries, the global market for Gentamicin remains robust, reflecting its essential role in treating bacterial infections worldwide.